BURNABY, British Columbia (AP) _ Xenon Pharmaceuticals Inc. (XENE) on Thursday reported a loss of $7.5 million in its first quarter.
On a per-share basis, the Burnaby, British Columbia-based company said it had a loss of 22 cents.
The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 31 cents per share.
The gene therapy biotech company posted revenue of $7.1 million in the period.
Xenon Pharmaceuticals shares have increased slightly more than 5% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $13.80, a rise of 40% in the last 12 months.